0001051578-26-000006.txt : 20260428 0001051578-26-000006.hdr.sgml : 20260428 20260428162358 ACCESSION NUMBER: 0001051578-26-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260424 FILED AS OF DATE: 20260428 DATE AS OF CHANGE: 20260428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PYOTT DAVID E I CENTRAL INDEX KEY: 0001051578 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39614 FILM NUMBER: 26908232 MAIL ADDRESS: STREET 1: 675 WEST KENDALL STREET STREET 2: HENRI A. TERMEER SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001819790 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 814717861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: (949) 409-9820 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 4 1 wk-form4_1777407836.xml FORM 4 X0609 4 2026-04-24 0 0001819790 Tarsus Pharmaceuticals, Inc. TARS 0001051578 PYOTT DAVID E I false C/O TARSUS PHARMACEUTICALS 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618 1 0 0 0 0 Common Stock 2026-04-24 4 M 0 1383 A 1383 D Common Stock 7991 I By the David E.I. Pyott Trust Restricted Stock Units 2026-04-24 4 M 0 1383 0 D Common Stock 1383 0 D The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vested in full on April 24, 2026, subject to the Reporting Person's continuous service. /s/ Scott Sieckert, Attorney-in-Fact 2026-04-28